Impaired brain glucose metabolism in patients with Down Syndrome

Journal of Neural Transmission, Supplement

Volumn , Issue 57, 1999, Pages 247-256

  Labudova, O ^c   Cairns, N ^a   Kitzmuller E ^c   Lubec, G ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF VIENNA   (Austria)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATE ISOMERASE; MESSENGER RNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DOWN SYNDROME; ENZYME ACTIVITY; FEMALE; FETUS; FRONTAL LOBE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; OCCIPITAL LOBE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL LOBE; AMINO ACID SEQUENCE; BRAIN; GENETICS; HIPPOCAMPUS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PRENATAL DEVELOPMENT; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BASE SEQUENCE; BRAIN; DOWN SYNDROME; FEMALE; FETUS; GLUCOSE-6-PHOSPHATE ISOMERASE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHOSPHOFRUCTOKINASE-1; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 0032585824     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6380-1_16     Document Type: Article

References (25)

1. Anneren KG, Korenberg JR, Epstein CJ (1987) Phosphofructokinase activity in fibroblasts aneuploid for chromosome 2. Hum Genet 76: 63-65
2. Baikie AG, Loder PB, de Grouchy GC, Pitt DB (1965) Phosphohexokinase activity in erythrocytes in mongolism: another possible marker for chromosome 21. Lancet i: 412-414
3. Bartels H, Kruse K (1968) Enzymbestimmungen in Erythrozyten bei Kindern mit Down Syndrome. Humangenetik 5: 305-309
4. Beutler E (1975) Red cell metabolism. A manual of biochemical methods, 2nd ed. Grune and Stratton, NY, pp 40-45
5. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
6. Burger PC, Vogel FS (1973) The development of pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am J Pathol 73: 457-476
7. Dani A, Pietrini P, Furey M, McIntosh CL, Horwitz B, Freo U, Alexander GE, Schapiro MB (1996) Brain cognition and metabolism of Down syndrome adults in association with development of dementia. Neuroreport 7: 2933-2936
8. Epstein CJ (1986) The consequences of chromosomal imbalance. Principles, mechanisms, and models. Cambridge University Press, New York
9. Epstein CJ (1992) Down Syndrome (Trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw Hill, New York, pp 749-794
10. Haxby JV, Schapiro MB (1988) Longitudinal study of neuropsychological function in older adults with Down syndrome. In: Epstein C, Nadel L (eds) Down Syndrome and Alzheimer disease. Wiley-Liss, New York, pp 35-50
11. Haxby JV, Duara R, Grady CL, Cutler NR, Rapoport SI (1985) Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J Cereb Blood Flow Metab 5: 193-200
12. Hsia DY, Justice P, Smith GF, Dowben RM (1971) Down's syndrome. A critical review of the biochemical and immunological data. Am J Dis Child 121: 153-163
13. Katz LA (1996) Transkingdom transfer of the phosphoglucose isomerase gene. J Mol Evol 43: 453-459
14. Labudova O, Lubec G (1998) cAMP upregulates the transposable element mys-1: a possible link between signaling and mobile DNA. Life Sci 62: 431-437
15. Lai F, Williams RS (1989) A prospective study of Alzheimer's disease in Down syndrome. Arch Neurol 46: 849-853
16. Layzer RB, Epstein CJ (1972) Phosphofructokinase and chromosome 21. Am J Hum Genet 24: 533-543
17. Mirra SS, Heyman A, McKeel D, Sumi S, Crain BJ (1991) The consortium to establish a registry for Alzheimer disease (CERAD). II. Standardisation of the neuropathological assessment of Alzheimer's disease. Neurology 41: 479-486
18. Pash J, Smithgall T, Bustin M (1991) Chromosomal protein HMG - 14 is overexpressed in Down syndrome. Exp Cell Res 193: 232-236
19. Pietrini P, Dani A, Furey ML, Alexander GE, Freo U, Grady CL, Mentis MJ, Mangot D, Simon EW, Horwitz B, Hazby JV, Schapiro MB (1997) Low glucose metabolism during brain stimulation in older Down's Syndrome subjects at risk for Alzheimer's disease prior to dementia. Am J Psychiatry 154: 1063-1069
20. Schapiro MB, Grady CL, Haxby JV (1992) Nature of mental retardation and dementia in Down's syndrome: study with PET, CT and neuropsychology. Neurobiol Aging 13: 723-734
21. Schmidt HJ, Schaum U, Pichotka JP (1977) The influence of mode and intensity of homogenization on the absolute value and stability of oxygen consumption of guinea pig liver homogenates. Z Naturforsch 32: 908-912
22. Seidl R, Greber S, Schuller E, Bernert G, Cairns N, Lubec G (1997) Evidence against increased oxidative DNA damage in Down Syndrome. Neurosci Lett 235: 137-140
23. Tierney MC, Fisher RH, Lewis AJ, Torzitto ML, Snow WG, Reid DW, Nieuwstraaten P, Van Rooijen LAA, Derks HJGM, Van Wijk R, Bischop A (1988) The NINCDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurology 38: 359-364
24. Vora S, Franke U (1981) Assignment of the human gene for liver-type 6-phosphofructokinase isoenzyme (PFK-L) to chromosome 21 by using somatic cell hybrids and monoclonal anti-L-antibody. Proc Natl Acad Sci USA 78: 3738-3742
25. Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17: 278-282